Cargando…

Development of drug resistance among HIV-1 F1 sub-type patients with treatment failure

Detalles Bibliográficos
Autores principales:	Temereanca, A, Sultana, CM, Manolescu, L, Vagu, C, Grancea, C, Ruta, S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The International AIDS Society 2010
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3112919/ http://dx.doi.org/10.1186/1758-2652-13-S4-P142

Ejemplares similares

Analysis of transmitted drug resistance, resistance mutations and future antiretroviral efficacy in HIV-1 subtype F infected-patients prior to therapy
por: Manolescu, LSC, et al.
Publicado: (2010)

High prevalence of asymptomatic HBV chronic carriage in HIV infected long term survivors
por: Temereanca, Aura, et al.
Publicado: (2014)

Strategies to overcome HIV drug resistance-current and future perspectives
por: Temereanca, Aura, et al.
Publicado: (2023)

OP3-5 Possible independent replication of HBV in the CNS of HIV-1 infected patients
por: Ruta, S., et al.
Publicado: (2009)

Serum Iron Markers in Patients With Chronic Hepatitis C Infection
por: Vagu, Codruta, et al.
Publicado: (2013)

Prevalence of resistance and HIV-1 protease mutation patterns after failures with fosamprenavir-containing regimens
por: Marcelin, AG, et al.
Publicado: (2010)

Hepatitis B Virus Genotypes and Antiviral Resistance Mutations in Romanian HIV-HBV Co-Infected Patients
por: Sultana, Camelia, et al.
Publicado: (2022)

Major HIV resistance mutations in untreated Romanian patients
por: Temereanca, A, et al.
Publicado: (2011)

Predictors of Chronic Hepatitis C Evolution in HIV Co-Infected Patients From Romania
por: Sultana, Camelia, et al.
Publicado: (2013)

Prevalence of drug resistance mutations in HIV-1 protease gene from North India
por: Azam, Mohd, et al.
Publicado: (2012)

Genetic variability and drug resistance mutations in HIV-1 infected individuals on HAART or drug naïve in Limbe, Cameroon
por: Agyingi, L, et al.
Publicado: (2012)

HIV drug resistance in children with treatment failure to first-line regimens in Ho Chi Minh City, Vietnam
por: Nhung, VTT, et al.
Publicado: (2010)

Detection of low frequency drug resistant mutations in antiretroviral-treated HIV-1C infections
por: Okatch, Harriet, et al.
Publicado: (2006)

Comparative biochemical analysis of wildtype and drug resistant HIV-1 integrase subtypes B and C
por: Bar-Magen, Tamara, et al.
Publicado: (2009)

Emergence of HIV-1 drug resistance in antiretroviral therapy experienced perinatally infected children in South India
por: Neogi, Ujjwal, et al.
Publicado: (2012)

Impact of IgA constant domain on HIV-1 neutralizing function of monoclonal antibody F425-A1g8
por: Yu, X, et al.
Publicado: (2012)

PMTCT of HIV-1 in Burkina Faso: evaluation of residual vertical transmission by PCR, molecular characterization of subtypes and determination of antiretroviral drugs resistance
por: Sagna, T, et al.
Publicado: (2014)

P17-15. Immunogenicity studies of chimeric yellow fever 17D viruses carrying HIV-1 p24 antigen
por: Franco, D, et al.
Publicado: (2009)

Genetically restricted HIV-1 sub populations are associated with and migrate within metastatic sites of AIDS-related lymphoma
por: McGrath, MS, et al.
Publicado: (2009)

Childhood TB in HIV ERA - in sub saharan africa
por: Anwar, MN
Publicado: (2015)

Is extended resistance to the historical antiretroviral drugs & drug classes still a risk factor for HIV progression?
por: Zaccarelli, M, et al.
Publicado: (2010)

Molecular epidemiology of antiretroviral resistance in therapy-experienced HIV-1 patients in Cuba (2009)
por: Pérez, L, et al.
Publicado: (2010)

Detection of HIV type 1 mutations on the pol region in untreated patients in Northern Vietnam: determination of drug resistance and subtypes
por: Ranger-Rogez, S, et al.
Publicado: (2010)

Relating protease inhibitor resistance at time of virological failure with drug exposure
por: Van Luin, M, et al.
Publicado: (2010)

P20-18. Diversity of Gag and Nef immunodominant regions in Brazilian HIV-1 B and F1 subtypes
por: Côrtes, FH, et al.
Publicado: (2009)

HIV-1 subtype B- and F1-infected subjects display higher cross-clade T-Cell response than subtype C-infected subjects
por: Côrtes, FH, et al.
Publicado: (2012)

Study on the HIV drug resistance and its influencing factors in China
por: Chongjian, Wang, et al.
Publicado: (2009)

Failure to define level 1 care
por: Fletcher, B, et al.
Publicado: (2011)

Factors associated with HIV and HCV infection among individuals with a history of injection drug use in Baltimore
por: Severtson, SG, et al.
Publicado: (2006)

HIV-1 evolution and drug resistance among patients receiving antiretroviral therapy in San Mateo county, California, 1997-2006
por: Dalai, Sudeb, et al.
Publicado: (2010)

HIV situation in the Greater Mekong Sub-Region bordering Thailand
por: Apidechkul, Tawatchai
Publicado: (2012)

Dynamics of HIV-1 Rev sub-nuclear trafficking reveal new insight into the role of RNA in the regulation of Rev nucleolar accumulation
por: Woods, Elena, et al.
Publicado: (2013)

Plasticity of HIV-specific CD8 T cell responses in untreated HIV-1 infection- a step towards a therapeutic vaccine against drug resistance mutations
por: Roider, J, et al.
Publicado: (2012)

Frequency of subtype B and F1 dual infection in HIV-1 positive, Brazilian men who have sex with men
por: Sanabani, Sabri Saeed, et al.
Publicado: (2012)

Factors associated with HIV and hepatitis C infection among regular and non-regular injection drug users in Baltimore
por: Graham, CM, et al.
Publicado: (2006)

HIV drug resistance profile of HIV-1 CRF 01_AE protease and integrase coding regions in HIV infected Cambodian patients failing LPV-based 2(nd) line antiretroviral regimen
por: Nouhin, Janin, et al.
Publicado: (2011)

Inhibition of HIV-1 subtype C by 2’F-RNA aptamers isolated against enveloped pseudovirus
por: London, GG, et al.
Publicado: (2012)

Molecular epidemiology and drug resistance prevalence of strains from newly diagnosed HIV-1 patients in Northern Greece during 2009-2010
por: Antoniadou, Zoe, et al.
Publicado: (2012)

Prevalence of HIV drug-resistance mutations in HIV-infected Mexican patients heavily experienced to antiretroviral therapy
por: Gaytán-Martínez, JE, et al.
Publicado: (2010)

Are the KIR3DS1homozygous and KIR3DL1*h/*y+HLA-B*57 genotypes associated protection from HIV by different routes of exposure?
por: Tallon, B, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_u3225jsfm8fdnj5flrngj2hiq4